Erytech announces trading resumption of its ordinary shares on Euronext Paris Post author:admERY Post published:November 10, 2017 Post category:Newsroom ERYTECH Pharma announces trading resumption of its ordinary shares on Euronext Paris as from 4:00pm CET. You Might Also Like ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update September 10, 2018 ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update March 4, 2021 ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer April 28, 2020
ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer April 28, 2020